Patel Sanj K
CHAIRMAN & CEO
Patel Sanj K has filed 10 SEC Form 4 filings (46 transaction rows) across 1 company, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: Sep 3, 2026.
On the most recent filing, Patel Sanj K is listed as CHAIRMAN & CEO at Kiniksa Pharmaceuticals International, plc. Inside the rolling window, Patel Sanj K reported no open-market purchases and 5 open-market sales totaling $29.4M in KNSA. The largest disclosed transaction in the window is a sale of 483,654 KNSA shares on Apr 28, 2026, worth $25.1M.
Companies traded
Other insiders at KNSA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$29.4M
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Oct 22, 2025 | KNSA | Sale | $3.8M |
| Oct 21, 2025 | KNSA | Sale | $1.5M |
| Oct 20, 2025 | KNSA | Sale | $877K |
| Oct 20, 2025 | KNSA | Sale | $3.8M |
Frequently asked questions
How many SEC Form 4 filings has Patel Sanj K made?
Patel Sanj K has filed 10 SEC Form 4 filings (46 transaction rows) across 1 company since 2025.
Which companies does Patel Sanj K trade?
Patel Sanj K has filed SEC Form 4 disclosures for 1 company, including KNSA.
When was Patel Sanj K's most recent SEC Form 4 filing?
Patel Sanj K's most recent SEC Form 4 filing on Tracefour is dated Sep 3, 2026.
What is Patel Sanj K's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Patel Sanj K is listed as CHAIRMAN & CEO.
What is Patel Sanj K's total buy and sell value in the current window?
Inside the rolling retention window, Patel Sanj K bought $0 and sold $29.4M based on SEC Form 4 filings.
What was Patel Sanj K's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 483,654 KNSA shares on 2026-04-28, worth $25.1M, per SEC Form 4 filings.